Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

EXAGEN INC. (XGN) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/01/2023 4 Adawi Kamal (CFO and Corporate Secretary) has filed a Form 4 on EXAGEN INC.
Txns: Granted 100,000 shares @ $0
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2022 4 Johnson Wendy S. (Director) has filed a Form 4 on EXAGEN INC.
Txns: Granted 9,000 options to buy @ $5.25, valued at $47.3k
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2022 4 Hooker Ana (Director) has filed a Form 4 on EXAGEN INC.
Txns: Granted 9,000 options to buy @ $5.25, valued at $47.3k
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2022 4 Zack Debra (Chief Medical Officer) has filed a Form 4 on EXAGEN INC.
Txns: Paid exercise price by delivering 3,241 shares @ $7.12, valued at $23.1k
03/02/2022 4 Hazeltine Mark (COO) has filed a Form 4 on EXAGEN INC.
Txns: Paid exercise price by delivering 3,241 shares @ $7.12, valued at $23.1k
03/02/2022 4 Adawi Kamal (CFO and Corporate Secretary) has filed a Form 4 on EXAGEN INC.
Txns: Paid exercise price by delivering 3,241 shares @ $7.12, valued at $23.1k
03/02/2022 4 Rocca Fortunato R. (President and CEO) has filed a Form 4 on EXAGEN INC.
Txns: Paid exercise price by delivering 4,322 shares @ $7.12, valued at $30.8k
02/08/2022 4 Zack Debra (Chief Medical Officer) has filed a Form 4 on EXAGEN INC.
Txns: Granted 50,000 shares @ $0
02/08/2022 4 Hazeltine Mark (COO) has filed a Form 4 on EXAGEN INC.
Txns: Granted 63,500 shares @ $0
02/08/2022 4 Adawi Kamal (CFO and Corporate Secretary) has filed a Form 4 on EXAGEN INC.
Txns: Granted 63,500 shares @ $0
02/08/2022 4 Rocca Fortunato R. (President and CEO) has filed a Form 4 on EXAGEN INC.
Txns: Granted 75,000 shares @ $0
09/07/2021 4 Johnson Wendy S. (Director) has filed a Form 4 on EXAGEN INC.
Txns: Bought 1,000 shares @ $14.02, valued at $14k
08/06/2021 4 TULLIS JAMES L L (Director) has filed a Form 4 on EXAGEN INC.
Txns: Sold 6,800 shares @ $10.7151, valued at $72.9k
08/04/2021 4 TULLIS JAMES L L (Director) has filed a Form 4 on EXAGEN INC.
Txns: Sold 1,800 shares @ $11.9191, valued at $21.5k
Sold 4,300 shares @ $11.7716, valued at $50.6k
Sold 2,100 shares @ $11.3891, valued at $23.9k
07/30/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/29/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2021 4 PALLARES EBETUEL (Director) has filed a Form 4 on EXAGEN INC.
Txns: Granted 9,000 options to buy @ $16.41, valued at $147.7k
06/21/2021 4 Stokes Frank (Director) has filed a Form 4 on EXAGEN INC.
Txns: Granted 15,000 options to buy @ $16.41, valued at $246.2k
06/21/2021 4 Robertson Bruce C (Director) has filed a Form 4 on EXAGEN INC.
Txns: Granted 9,000 options to buy @ $16.41, valued at $147.7k
06/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2021 4 Johnson Wendy S. (Director) has filed a Form 4 on EXAGEN INC.
Txns: Granted 9,000 options to buy @ $16.41, valued at $147.7k
06/21/2021 4 Birk Brian (Director) has filed a Form 4 on EXAGEN INC.
Txns: Granted 9,000 options to buy @ $16.41, valued at $147.7k
06/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/17/2021 4 Hazeltine Mark (COO) has filed a Form 4 on EXAGEN INC.
Txns: Exercised 1,934 options to buy @ $0.26, valued at $502.8
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy